GULFPORT, MISSISSIPPI, UNITED STATES, February 28, 2024 /EINPresswire.com/ -- Attention Deficit Disorder (ADD) in adults is a complex neurodevelopmental disorder ...
Newron Pharmaceuticals’ add-on schizophrenia treatment improved both positive and negative symptoms as well as severity in patients with the disorder during a phase 2/3 study. The Italian biotech is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback